BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 2355226)

  • 1. [3H]N-methylscopolamine binding studies reveal M2 and M3 muscarinic receptor subtypes on cerebellar granule cells in primary culture.
    Alonso R; Didier M; Soubrie P
    J Neurochem; 1990 Jul; 55(1):334-7. PubMed ID: 2355226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. M1 and M3 muscarinic receptor subtypes in rat forebrain.
    Pavia J; Marquez E; Laukkonen S; Martos F; Gómez A; Sánchez de la Cuesta F
    Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):653-60. PubMed ID: 1770828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
    Flynn DD; Mash DC
    Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of muscarinic receptors in dog tracheal smooth muscle cells.
    Yang CM
    J Auton Pharmacol; 1991 Feb; 11(1):51-61. PubMed ID: 2030109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The binding of [3H]4-diphenylacetoxy-N-methylpiperidine methiodide to longitudinal ileal smooth muscle muscarinic receptors.
    Michel AD; Whiting RL
    Eur J Pharmacol; 1990 Feb; 176(2):197-205. PubMed ID: 2311667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain.
    Waelbroeck M; Tastenoy M; Camus J; Christophe J
    Mol Pharmacol; 1990 Aug; 38(2):267-73. PubMed ID: 2385234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studies.
    Cortés R; Probst A; Tobler HJ; Palacios JM
    Brain Res; 1986 Jan; 362(2):239-53. PubMed ID: 3753655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscarinic receptor subtypes in human and rat colon smooth muscle.
    Gómez A; Martos F; Bellido I; Marquez E; Garcia AJ; Pavia J; Sanchez de la Cuesta F
    Biochem Pharmacol; 1992 Jun; 43(11):2413-9. PubMed ID: 1610405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affinities of muscarinic drugs for [3H]N-methylscopolamine (NMS) and [3H]oxotremorine (OXO) binding to a mixture of M1-M4 muscarinic receptors: use of NMS/OXO-M ratios to group compounds into potential agonist, partial agonist, and antagonist classes.
    Sharif NA; Williams GW; DeSantis LM
    Neurochem Res; 1995 Jun; 20(6):669-74. PubMed ID: 7566362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M3 muscarinic cholinoceptors are linked to phosphoinositide metabolism in rat cerebellar granule cells.
    Whitham EM; Challiss RA; Nahorski SR
    Eur J Pharmacol; 1991 Mar; 206(3):181-9. PubMed ID: 1649760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affinity of muscarinic receptor antagonists for three putative muscarinic receptor binding sites.
    Delmendo RE; Michel AD; Whiting RL
    Br J Pharmacol; 1989 Feb; 96(2):457-64. PubMed ID: 2924085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of muscarinic receptors in neonatal rat cardiomyocytes.
    Yang CM; Chen FF; Sung TC; Hsu HF; Wu D
    Am J Physiol; 1993 Sep; 265(3 Pt 1):C666-73. PubMed ID: 8214023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atropine and glycopyrronium show similar binding patterns to M2 (cardiac) and M3 (submandibular gland) muscarinic receptor subtypes in the rat.
    Gomez A; Bellido I; Sanchez de la Cuesta F
    Br J Anaesth; 1995 May; 74(5):549-52. PubMed ID: 7772430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of cholinergic muscarinic receptors in the rabbit iris.
    Honkanen RE; Abdel-Latif AA
    Biochem Pharmacol; 1988 Jul; 37(13):2575-83. PubMed ID: 3291881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PC12 phaeochromocytoma cells contain an atypical muscarinic receptor binding site.
    Michel AD; Stefanich E; Whiting RL
    Br J Pharmacol; 1989 Jul; 97(3):914-20. PubMed ID: 2758243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ; Tran LP
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of porcine coronary muscarinic receptors.
    Entzeroth M; Doods HN; Mayer N
    Naunyn Schmiedebergs Arch Pharmacol; 1990 May; 341(5):432-8. PubMed ID: 2366878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-[3H]methylscopolamine labeling of non-M1, non-M2 muscarinic receptor binding sites in rat brain.
    Smith TD; Annis SJ; Ehlert FJ; Leslie FM
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1173-81. PubMed ID: 2005579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agonist-induced down-regulation and antagonist-induced up-regulation of m2- and m3-muscarinic acetylcholine receptor mRNA and protein in cultured cerebellar granule cells.
    Fukamauchi F; Saunders PA; Hough C; Chuang DM
    Mol Pharmacol; 1993 Nov; 44(5):940-9. PubMed ID: 8246917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different antagonist binding properties of rat pancreatic and cardiac muscarinic receptors.
    Waelbroeck M; Camus J; Winand J; Christophe J
    Life Sci; 1987 Nov; 41(19):2235-40. PubMed ID: 3118122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.